1Milano S, Cillari E D,Agostono P, et al. Ex uiuo evidence for PGE2 and L T B4involvement in cutaneous leishmaniasis:relation with ingection status and cytokine production[J].Parasitology, 1996;112:13
2Drazen JM, Austen KF, Lewis RA. Compaeative airway and vascular activities of leukotrienes C-1 and D in vito and in vitro [J].Proc Natl Acad Sei USA, 1980;77:4354
4Istael E, Denarkarian R, Rosenberj M, The effets of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air[J].New Engl J Med, 1990;323:1740
5Meltzer S, Hasday JD, Cohn J. Bleecker ER. Inhibition of exercise-induced bronchospasm by zyleuton: a 5-lipoxygenase inhibitor [J] . Am J Respir Crit Care Med,1996;153:931
6Lee Th, Walport MJ ,Wilkinson AN , et al . Slow reacting substance of anaphylaxis antagonist FPL55712 in chronic asthma. [J] Lancet, 1981;2:304.
7Britton JR, Hanley SP,Tattersfield AE. The effect of an oral leukotriene D4antagonist L-649,923 on the response to inhaled antigen in asthma[J].J Allergy Clin Immunol, 1987;79:811
8Bisgaard H ,Leukotriene Modifiers in Pediatric Asthma Management[J]. Pediatrics 2001 Feb;107(2):381
9Stevenson DD, Simon RA, Mathison DA, et al . Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics[J].Ann Allergy Asthma Immunol 2000 Dec;85(6 Pt 1):477
